About Bevacirel Bevacizumab Injection
Description:
Bevacirel (Bevacizumab) Injection is a recombinant humanized monoclonal antibody designed to inhibit vascular endothelial growth factor (VEGF), thereby preventing the formation of new blood vessels that supply tumors. It is primarily used as an anti-cancer therapy in the treatment of various malignancies, including colorectal cancer, lung cancer, renal cell carcinoma, glioblastoma, and cervical cancer.
Key Features:
-
Targets VEGF to slow tumor growth
-
Administered intravenously under medical supervision
-
Suitable for combination therapy with chemotherapy or as monotherapy in specific cancers
-
Helps improve patient survival and manage tumor progression
Indications:
Dosage & Administration:
Bevacirel Injection should be administered as per the oncologists prescription. Dose varies depending on the type of cancer, patient condition, and combination with other therapies.
Packaging:
Available in 100 mg/4 mL vials for intravenous infusion.
Storage:
Store at 28C. Protect from light. Do not freeze.
Safety Information:
Use under strict medical supervision. May cause side effects including hypertension, bleeding, proteinuria, delayed wound healing, and gastrointestinal perforation.
Targeted Cancer Therapy with Reliable EfficacyBevacirel Bevacizumab Injection works by inhibiting vascular endothelial growth factor (VEGF), a key protein that promotes tumor blood vessel formation. By blocking VEGF, this monoclonal antibody helps restrict the blood supply essential for tumor growth, thereby impeding cancer progression. Its targeted mechanism has demonstrated benefits across several advanced and metastatic cancers, supporting improved patient outcomes.
Safe Handling, Storage, and AdministrationBevacirel is supplied as a single-use, sterile, preservative-free vial for intravenous infusion. Store it between 2C and 8C in a refrigerator, avoiding freezing and light exposure. It has no characteristic odor and appears as a clear to slightly opalescent, colorless to pale brownish-yellow solution. This injectable should only be administered in authorized medical settings by trained professionals.
FAQ's of Bevacirel Bevacizumab Injection:
Q: How is Bevacirel Bevacizumab Injection administered?
A: Bevacirel is administered intravenously by a healthcare professional in a clinical setting. The dosage and infusion schedule depend on your specific cancer diagnosis and medical protocol recommended by your doctor.
Q: What types of cancer can Bevacirel Bevacizumab Injection treat?
A: This injection is approved for use in several types of cancer, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, ovarian and cervical cancer, and renal cell carcinoma, among others.
Q: When and how should Bevacirel be stored to maintain potency?
A: Bevacirel should be kept refrigerated at 2C to 8C. Do not freeze or shake the vial, and always protect it from direct light to preserve its effectiveness throughout its 24-month shelf life.
Q: Where can I obtain Bevacirel Bevacizumab Injection?
A: Bevacirel is a prescription-only medication available through authorized hospitals, cancer treatment centers, or pharmacies. It is supplied and distributed by Reliance Life Sciences across India and select global markets.
Q: What benefits does Bevacirel offer in cancer therapy?
A: By inhibiting VEGF, Bevacirel helps reduce blood supply to tumors, potentially slowing or stopping cancer progression. This targeted approach often enhances treatment outcomes when used alongside chemotherapy or other therapies.
Q: What is the preparation process before administering Bevacirel?
A: Before administration, Bevacirel should be visually inspected for clarity and particulate matter. Only trained healthcare professionals can prepare and infuse the injection, ensuring safety and accuracy in dosage.
Q: Is Bevacirel injection suitable for repeated use?
A: Bevacirel is supplied in single-use vials and is preservative-free. Each vial should be used for only one dose and any remaining solution must be discarded, adhering to recommended medical guidelines.